
The episode discusses innovative delivery mechanisms for anti-VEGF therapies in retinal treatment.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/COPE information, and to apply for credit, please visit us at PeerView.com/PVU865. CME/COPE credit will be available until April 26, 2027. Reimagining Retinal Treatment: The Promise of Novel Delivery Mechanisms for Anti-VEGF Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an educational grant from Genentech, a member of the Roche Group. Disclosure information is available at the beginning of the video presentation.
Guest: Christina Y. Weng, MD, MBA
Genentech
Organizations: PeerView Institute for Medical Education, Accreditation Council for Continuing Medical Education, Accreditation Council for Pharmacy Education, American Nurses Credentialing Center, Roche Group
Explore listener stats, chart rankings, contacts and more on the PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast podcast page.